Balakrishnan Lata, Milavetz Barry
Department of Biochemistry and Molecular Biology, University of North Dakota, Grand Forks, North Dakota, USA.
Virol J. 2008 Mar 19;5:43. doi: 10.1186/1743-422X-5-43.
The effects of histone deacetylase inhibitor (HDACi) treatment on SV40 transcription and replication were determined by monitoring the levels of early and late expression, the extent of replication, and the percentage of SV40 minichromosomes capable of transcription and replication following treatment with sodium butyrate (NaBu) and trichostatin A (TSA).
The HDACi treatment was found to maximally stimulate early transcription at early times and late transcription at late times through increased numbers of minichromosomes which carry RNA polymerase II (RNAPII) transcription complexes and increased occupancy of the transcribing minichromosomes by RNAPII. HDACi treatment also partially relieved the normal down-regulation of early transcription by T-antigen seen later in infection. The increased recruitment of transcribing minichromosomes at late times was correlated to a corresponding reduction in SV40 replication and the percentage of minichromosomes capable of replication.
These results suggest that histone deacetylation plays a critical role in the regulation of many aspects of an SV40 lytic infection.
通过监测早期和晚期表达水平、复制程度以及用丁酸钠(NaBu)和曲古抑菌素A(TSA)处理后能够进行转录和复制的SV40微型染色体的百分比,确定组蛋白去乙酰化酶抑制剂(HDACi)处理对SV40转录和复制的影响。
发现HDACi处理通过增加携带RNA聚合酶II(RNAPII)转录复合物的微型染色体数量以及增加RNAPII对转录微型染色体的占据,在早期最大程度地刺激早期转录,在晚期最大程度地刺激晚期转录。HDACi处理还部分缓解了感染后期T抗原对早期转录的正常下调。晚期转录微型染色体募集的增加与SV40复制的相应减少以及能够复制的微型染色体的百分比相关。
这些结果表明组蛋白去乙酰化在SV40裂解感染的许多方面的调节中起关键作用。